Notably, CAR constructs incorporating the 2B4 co-stimulatory domain in combination with either CD3ζ or DAP12 demonstrated cytotoxicity slightly higher to that of BBζ in vitro, highlighting the robust anti-tumor activity of these designs. Here, TYROBP is linked to neoplasm.